Battling Arthritis

Orencia (abatacept) - a product of Bristol-Myers Squibb -  is in the news today.

ORENCIA® (abatacept) is a prescription medicine that can reduce signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA) — including those who have not been helped enough by other medicines for RA. ORENCIA can further damage the bones and joints which can also reduce signs and symptoms in children and adolescents 6 years of age and older with moderate to severe polyarticular juvenile idiopathic arthritis (JIA).

More →

Share This

The arthritis drug Orencia has been approved as the treatment when all other treatments fail.

In the UK, after being ruled not cost effective The National Institute for Health and Clinical Excellence (NICE), is bad news to all the people there (who has been under treatment with Orencia) with aggressive rheumatoid arthritis.

Such a ruling went down despite appeals by The National Rheumatoid Arthritis Society (NRAS) and Bristol-Myers Squibb — maker of Orencia (abatacept). More →

Share This